KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Change in Account Payables: 2024-2025

Historic Change in Account Payables for Aurinia Pharmaceuticals (AUPH) over the last 2 years, with Sep 2025 value amounting to -$1.1 million.

  • Aurinia Pharmaceuticals' Change in Account Payables fell 337.15% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.7 million, marking a year-over-year change of. This contributed to the annual value of $860,000 for FY2024, which is 30.65% down from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Change in Account Payables of -$1.1 million as of Q3 2025, which was down 21.86% from -$901,000 recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Change in Account Payables ranged from a high of $2.7 million in Q2 2024 and a low of -$3.7 million during Q4 2024.
  • Moreover, its 2-year median value for Change in Account Payables was -$901,000 (2025), whereas its average is -$301,857.
  • Data for Aurinia Pharmaceuticals' Change in Account Payables shows a maximum YoY slumped of 337.15% (in 2025) over the last 5 years.
  • Aurinia Pharmaceuticals' Change in Account Payables (Quarterly) stood at -$3.7 million in 2024, then slumped by 337.15% to -$1.1 million in 2025.
  • Its last three reported values are -$1.1 million in Q3 2025, -$901,000 for Q2 2025, and -$974,000 during Q1 2025.